Intracellular checkpoints for NK cell cancer immunotherapy
Frontiers of Medicine · 2024-10 · 18 (5) · 763-777
DOI: 10.1007/s11684-024-1090-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers of Medicine, online erschienen am 28.09.2024. Verfasst von Yingying Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese A…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 165 Literaturangaben.
Abstract (Originalsprache)
Natural killer (NK) cells are key innate immune lymphocytes, which play important roles against tumors. However, tumor-infiltrating NK cells are always hypofunctional/exhaustive. On the one hand, this state is contributed by context-dependent interactions between inhibitory NK cell checkpoint receptors and their ligands, which usually vary in different tumor types and stages during tumor development. On the other hand, the inhibitory functions of intracellular checkpoint molecules of NK cells are more similar across different tumor types, representing common mechanisms limiting the potential of NK cell therapy. In this review, representative NK cell intracellular checkpoint molecules in different aspects of NK cell biology were reviewed, and therapeutic potentials were discussed by targeting these molecules to promote antitumor NK cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
- Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
- Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, 530021, China.
- Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, 530021, China.
- Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Key Laboratory of Colleges and Universities, Nanning, 530021, China.
- Collaborative Innovation Center of Regenerative Medicine and Medical BioResource Development and Application, Guangxi Medical University, Nanning, 530021, China.
Zitieren
APA
Huang, Y., Tian, Z., & Bi, J. (2024). Intracellular checkpoints for NK cell cancer immunotherapy. Frontiers of Medicine, 18(5), 763-777. https://doi.org/10.1007/s11684-024-1090-6
Vancouver
Huang Y, Tian Z, Bi J. Intracellular checkpoints for NK cell cancer immunotherapy. Frontiers of Medicine. 2024;18(5):763-777. doi:10.1007/s11684-024-1090-6
BibTeX
@article{Huang2024,
author = {Huang, Yingying and Tian, Zhigang and Bi, Jiacheng},
title = {Intracellular checkpoints for NK cell cancer immunotherapy},
journal = {Frontiers of Medicine},
year = {2024},
volume = {18},
number = {5},
pages = {763--777},
doi = {10.1007/s11684-024-1090-6}
}
EUVIMED